Repository logo
 

Huntingtin is required for ER-to-Golgi transport and for secretory vesicle fusion at the plasma membrane.


Change log

Authors

Brandstaetter, Hemma 
Kruppa, Antonina J 

Abstract

Huntingtin is a large membrane-associated scaffolding protein that associates with endocytic and exocytic vesicles and modulates their trafficking along cytoskeletal tracks. Although the progression of Huntington's disease is linked to toxic accumulation of mutant huntingtin protein, loss of wild-type huntingtin function might also contribute to neuronal cell death, but its precise function is not well understood. Therefore, we investigated the molecular role of huntingtin in exocytosis and observed that huntingtin knockdown in HeLa cells causes a delay in endoplasmic reticulum (ER)-to-Golgi transport and a reduction in the number of cargo vesicles leaving the trans-Golgi network. In addition, we found that huntingtin is required for secretory vesicle fusion at the plasma membrane. Similar defects in the early exocytic pathway were observed in primary fibroblasts from homozygous Htt(140Q/140Q) knock-in mice, which have the expansion inserted into the mouse huntingtin gene so lack wild-type huntingtin expression. Interestingly, heterozygous fibroblasts from a Huntington's disease patient with a 180Q expansion displayed no obvious defects in the early secretory pathway. Thus, our results highlight the requirement for wild-type huntingtin at distinct steps along the secretory pathway.

Description

Keywords

ER, Exocytosis, Golgi, Huntingtin, Vesicle fusion, Animals, Cell Membrane, Disease Models, Animal, Endoplasmic Reticulum, Fibroblasts, Golgi Apparatus, Green Fluorescent Proteins, HeLa Cells, Homozygote, Humans, Huntingtin Protein, Huntington Disease, Mice, Microscopy, Fluorescence, Nerve Tissue Proteins, Nuclear Proteins, Protein Binding, Protein Transport, RNA, Small Interfering, Secretory Vesicles, trans-Golgi Network

Journal Title

Dis Model Mech

Conference Name

Journal ISSN

1754-8403
1754-8411

Volume Title

7

Publisher

The Company of Biologists
Sponsorship
Biotechnology and Biological Sciences Research Council (BB/K001981/1)
Medical Research Council (MR/K000888/1)
Wellcome Trust (100140/Z/12/Z)
Wellcome Trust (086743/Z/08/Z)
This work was supported by the Cure Huntingtin’s Disease Initiative (CHDI) (H.B. and A.J.K.), the Wellcome Trust (grant number 086743 to F.B.) and the Medical Research Council (grant number MR/K000888/1 to F.B). The CIMR is in receipt of a strategic award from the Wellcome Trust (grant number 100140).